Katrina A. Bramstedt, PhD, MA and Jean-Baptiste Hoang
Some technological and policy strategies for increasing organ supplies are ethically and legally proven to work. Consider best next steps for global education efforts to raise organ donation awareness.
AMA J Ethics. 2016;18(2):143-152. doi:
10.1001/journalofethics.2017.18.2.pfor2-1602.
Charles E. Binkley, MD, Michael S. Politz, MA, and Brian P. Green, PhD
If the safe-and-effective standard for judging devices’ potential as therapy or enhancement is inadequate, one might wonder whether BCI regulation should be overseen by the FDA.
AMA J Ethics. 2021;23(9):E745-749. doi:
10.1001/amajethics.2021.745.
Dr Charles Binkley joins Ethics Talk to discuss his article, coauthored with Michael Politz and Dr Brian Green: "Who, If Not the FDA, Should Regulate Implantable Brain-Computer Interface Devices?"
The DSM-5 Task Force’s handling of the ethical controversy over the bereavement exclusion demonstrates the need for more inclusive deliberative processes.
AMA J Ethics. 2017;19(2):192-198. doi:
10.1001/journalofethics.2017.19.2.pfor2-1702.
Feminism plays critical roles in innovating health care policies and practices. Feminist insights into clinicians as gatekeepers to gender-transition interventions can help resist tendencies to pathologize transgender.
AMA J Ethics. 2016;18(11):1132-1138. doi:
10.1001/journalofethics.2016.18.11.msoc1-1611.